Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report

BACKGROUND: Portopulmonary hypertension (PPH) is a relatively rare but well-recognized complication of end-stage liver disease. Moderate or severe PPH (mean pulmonary artery pressure [mPAP] ≥ 35 mmHg) is usually a contraindication for liver transplantation due to high operation-related mortality. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoe, Takashi, Tanaka, Asuka, Ishiyama, Kohei, Ide, Kentaro, Tashiro, Hirotaka, Ohdan, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803166/
https://www.ncbi.nlm.nih.gov/pubmed/29417353
http://dx.doi.org/10.1186/s40792-018-0423-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803166/
https://www.ncbi.nlm.nih.gov/pubmed/29417353
http://dx.doi.org/10.1186/s40792-018-0423-6

Ejemplares similares